KRISTINE TROUT: Open Payments
NPI 1902908122 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 53 payments from 16 companies in 2025. Trend: 2023 $3,407 · 2024 $3,113 · 2025 $1,592
Food & beverage: $1,592
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 6 | $503 |
| Janssen Biotech, Inc. | 5 | $198 |
| ABBVIE INC. | 12 | $176 |
| PFIZER INC. | 8 | $139 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| Madrigal Pharmaceuticals | 2 | $85 |
| QOL Medical, LLC | 2 | $55 |
| EVOKE PHARMA, INC. | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| VIVUS LLC | 2 | $49 |
Products named: RELTONE 200 MG, TREMFYA, DUPIXENT, REZDIFFRA, VELSIPITY, XELJANZ, RINVOQ, Sucraid.
Industry payments across GA — which companies pay providers there.
